Krishna Yeshwant is a director of Verve Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Verve Therapeutics, Inc.
5 Dec 23
4
EQRx, Inc.
9 Nov 23
4
Verve Therapeutics, Inc.
20 Jun 23
4
Verve Therapeutics, Inc.
8 Nov 22
4
Verve Therapeutics, Inc.
4 Nov 22
4
Verve Therapeutics, Inc.
2 Nov 22
4
EQRx, Inc.
4 Oct 22
4
Verve Therapeutics, Inc.
13 Jun 22
3
EQRx, Inc.
20 Dec 21
4
Verve Therapeutics, Inc.
22 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Dec 23 | VERV Verve Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 10 | 1,800,000 | 18.00 mm | 1,800,000 |
9 Nov 23 | EQRX EQRx | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.95 | 101,010 | 500.00 k | 0 |
15 Jun 23 | VERV Verve Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 19.84 | 26,642 | 528.58 k | 26,642 |